These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 27312782
1. Urinary angiotensin converting enzyme 2 is strongly related to urinary nephrin in type 2 diabetes patients. Mariana CP, Ramona PA, Ioana BC, Diana M, Claudia RC, Stefan VD, Maria KI. Int Urol Nephrol; 2016 Sep; 48(9):1491-7. PubMed ID: 27312782 [Abstract] [Full Text] [Related]
2. Urinary angiotensin converting enzyme 2 increases in patients with type 2 diabetic mellitus. Liang Y, Deng H, Bi S, Cui Z, A L, Zheng D, Wang Y. Kidney Blood Press Res; 2015 Sep; 40(2):101-10. PubMed ID: 25791940 [Abstract] [Full Text] [Related]
5. Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion. Chodavarapu H, Grobe N, Somineni HK, Salem ES, Madhu M, Elased KM. PLoS One; 2013 Sep; 8(4):e62833. PubMed ID: 23646149 [Abstract] [Full Text] [Related]
6. Urinary ACE2 is associated with urinary L-FABP and albuminuria in patients with chronic kidney disease. Abe M, Maruyama N, Oikawa O, Maruyama T, Okada K, Soma M. Scand J Clin Lab Invest; 2015 Sep; 75(5):421-7. PubMed ID: 26067610 [Abstract] [Full Text] [Related]
12. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker. Furuhashi M, Moniwa N, Mita T, Fuseya T, Ishimura S, Ohno K, Shibata S, Tanaka M, Watanabe Y, Akasaka H, Ohnishi H, Yoshida H, Takizawa H, Saitoh S, Ura N, Shimamoto K, Miura T. Am J Hypertens; 2015 Jan; 28(1):15-21. PubMed ID: 24842388 [Abstract] [Full Text] [Related]
14. Urinary angiotensin-converting enzyme 2 and its activity in cats with chronic kidney disease. Kuo TC, Hsu WL, Wu VC, Jan TR, Tsai PJ, Lee YJ. Front Vet Sci; 2024 Jan; 11():1362379. PubMed ID: 38756510 [Abstract] [Full Text] [Related]
15. High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria. Park SE, Kim WJ, Park SW, Park JW, Lee N, Park CY, Youn BS. Eur J Endocrinol; 2013 Feb; 168(2):203-10. PubMed ID: 23144053 [Abstract] [Full Text] [Related]
16. Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus. Tkác I, Salagovic J, Kozárová M, Javorský M, Tkácová R, Kalina I. Wien Klin Wochenschr; 2003 Dec 15; 115(23):835-9. PubMed ID: 14740347 [Abstract] [Full Text] [Related]
17. Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients. Young RP, Chan JC, Critchley JA, Poon E, Nicholls G, Cockram CS. Diabetes Care; 1998 Mar 15; 21(3):431-7. PubMed ID: 9540028 [Abstract] [Full Text] [Related]
18. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. Wu C, Wang Q, Lv C, Qin N, Lei S, Yuan Q, Wang G. Diabetes Res Clin Pract; 2014 Nov 15; 106(2):343-50. PubMed ID: 25263500 [Abstract] [Full Text] [Related]
19. An evaluation of renin-angiotensin system markers in youth with type 2 diabetes and associations with renal outcomes. Dart AB, Wicklow B, Scholey J, Sellers EA, Dyck J, Mahmud F, Sochett E, Hamilton J, Blydt-Hansen T, Burns K. Pediatr Diabetes; 2020 Nov 15; 21(7):1102-1109. PubMed ID: 32657529 [Abstract] [Full Text] [Related]